Therapeutic drug monitoring opportunities in cancer therapy

被引:23
作者
McLeod, HL
机构
[1] Department of Medicine and Therap., University of Aberdeen, Polworth Building, Aberdeen AB25 2ZD, Foresterhill
关键词
therapeutic drug monitoring; cancer therapeutics; pharmacokinetics; cancer chemotherapy;
D O I
10.1016/S0163-7258(96)00201-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cancer is a common cause of death, and improvements in treatment are desperately needed. The high degree of variation in systemic exposure far a given dose and the relationships between blood concentrations and either toxic or antitumor effects would suggest that therapeutic drug monitoring is a potential mechanism for improving the treatment of individual patients. In this review, the case for therapeutic drug monitoring is made in a select number of commonly used cancer drugs and areas that require more concerted effort are highlighted. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:39 / 54
页数:16
相关论文
共 96 条
[61]  
MILLER AA, 1994, CANCER RES, V54, P2080
[62]   PHARMACODYNAMICS OF 3 DAILY INFUSIONS OF ETOPOSIDE IN PATIENTS WITH EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER [J].
MILLER, AA ;
TOLLEY, EA ;
NIELL, HB ;
STEWART, CF ;
GRIFFIN, JP .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 31 (02) :161-166
[63]   CLINICAL AND PHARMACOLOGICAL ANALYSIS OF HYPERFRACTIONATED DAILY ORAL ETOPOSIDE [J].
MINAMI, H ;
ANDO, Y ;
SAKAI, S ;
SHIMOKATA, K .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (01) :191-199
[64]   PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF A 14-DAY INFUSION OF ETOPOSIDE IN PATIENTS WITH LUNG-CANCER [J].
MINAMI, H ;
SHIMOKATA, K ;
SAKA, H ;
SAITO, H ;
ANDO, Y ;
SENDA, K ;
NOMURA, F ;
SAKAI, S .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (08) :1602-1608
[65]   CARBOPLATIN PHARMACOKINETICS IN CHILDREN - THE DEVELOPMENT OF A PEDIATRIC DOSING FORMULA [J].
NEWELL, DR ;
PEARSON, ADJ ;
BALMANNO, K ;
PRICE, L ;
WYLLIE, RA ;
KEIR, M ;
CALVERT, AH ;
LEWIS, IJ ;
PINKERTON, CR ;
STEVENS, MCG .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (12) :2314-2323
[66]  
NEWELL DR, 1994, ANN ONCOL S5, V5, P164
[67]   CLINICAL RELEVANCE OF BIOCHEMICAL MODULATION OF 5-FLUOROURACIL [J].
PETERS, GJ ;
VANGROENINGEN, CJ .
ANNALS OF ONCOLOGY, 1991, 2 (07) :469-480
[68]   24-HOUR PLASMA ETOPOSIDE PROFILE AFTER ORAL AND INTRAVENOUS ADMINISTRATION IN CHILDREN [J].
PINKERTON, CR ;
DICK, G ;
AHERNE, GW .
EUROPEAN JOURNAL OF CANCER, 1993, 29A (10) :1479-1481
[69]   ASSOCIATION OF INTRATUMORAL PHARMACOKINETICS OF FLUOROURACIL WITH CLINICAL-RESPONSE [J].
PRESANT, CA ;
WOLF, W ;
WALUCH, V ;
WISEMAN, C ;
KENNEDY, P ;
BLAYNEY, D ;
BRECHNER, RR .
LANCET, 1994, 343 (8907) :1184-1187
[70]   PHARMACODYNAMICS IN CANCER-THERAPY [J].
RATAIN, MJ ;
SCHILSKY, RL ;
CONLEY, BA ;
EGORIN, MJ .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (10) :1739-1753